UH Neurological Institute
Showing of 25 results
Two UH Physician-Scientists to Receive 2024 Top Ten Clinical Research Achievement Awards
Mehdi Shishehbor, DO, MPH, PhD, and Amrou Sarraj, MD, will receive honors from the Clinical Research Forum in a ceremony to be held April 2 in Las Vegas.
International Study Finds Thrombectomy Highly Effective Long-Term Treatment for Large Strokes
Led by University Hospitals stroke director Amrou Sarraj, MD, SELECT2 study results in The Lancet presented at International Stroke Conference.
University Hospitals Now Offering FDA-Approved Medication for Treatment of Alzheimer’s Disease
UH Brain Health & Memory Center Begins LEQEMBI® (lecanemab) Infusions for Patients
University Hospitals Selected as Study Site for the Black and African American Connections to Parkinson’s Disease (BLAAC PD) Study
BLAAC PD is an initiative of GP2 in a dedicated effort to better understand the genetic basis of Parkinson’s disease (PD) among underrepresented populations by genotyping more than 150,000 individuals from around the world.
New Major International Study Finds Thrombectomy Highly Effective Treatment for Large Strokes
Led by University Hospitals stroke director Amrou Sarraj, MD, SELECT2 study results in New England Journal of Medicine presented at International Stroke Conference
New ‘Gold Standard’ Surgical Textbook Co-written by Hospital System CEO
Surgery of the Cerebellopontine Angle, Second Edition co-authored by UH CEO Cliff Megerian MD, FACS, with neurosurgeons Nicholas Bambakidis, MD, and Robert Spetzler, MD, FACS
University Hospitals Part of Study Aiming to Prevent Alzheimer's Disease
November is Alzheimer’s Disease Awareness Month.
Several UH Hospitals Recognized by American Heart Association for Quality Stroke Care
The American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Quality Achievement Awards, achieved by UH medical centers, commitment to ensuring stroke patients receive the best and most appropriate treatment.